ACLARIS THERAPEUTICS
Aclaris Therapeutics started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies. It is committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. Aclaris is focused on market segments with no FDA-approved medications or where treatment gaps exist.
ACLARIS THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.aclaristx.com
Total Employee:
101+
Status:
Active
Contact:
(484) 324-7933
Email Addresses:
[email protected]
Total Funding:
219.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Domain Not Resolving
Similar Organizations
Rani Therapeutics
Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Verseon
Verseon’s breakthroughs in computational chemistry, AI, & synthesis create novel pharmaceuticals. Atom by atom, we drive innovation.
Valted Seq
Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.
Viracta Therapeutics
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
MediciNova
MediciNova is a biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.
MDI Therapeutics
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
Moleculin
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Medeor Therapeutics
Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.
Medicure
Medicure is a specialty pharmaceutical Company engaged in the research, clinical development and commercialization of human therapeutics.
Mapp Biopharmaceutical
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.
Lantern Pharma
Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics
Agilis Biotherapeutics
Agilis Biotherapeutics designs and engineers DNA-based therapeutics for genetic disorders.
ARS Pharmaceuticals
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Atrin Pharmaceuticals
Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.
Acylin Therapeutics
Acylin Therapeutics operates in the pharmaceutical and drug manufacturing industry developing inhibitors of cellular acetylation.
Advicenne
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Aileron Therapeutics
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Allena Pharmaceuticals
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Evrys Bio
Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.
Iterion Therapeutics
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Brooklyn ImmunoTherapeutics
Brooklyn ImmunoTherapeutics is a clinical=stage biopharmaceutical company discovers and develops a novel cytokine-based therapy.
Boston Immune Technologies & Therapeutics
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
Faraday Pharmaceuticals
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Telesta Therapeutics
Telesta Therapeutics is a biopharmaceutical company focused on the licensing, acquisition, and development of transformational therapeutics.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Spectrum Antimicrobials
Spectrum Antimicrobials is a pharmaceutical company that specializes in the fields of drug development, antibiotics, and therapeutics.
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
Sollis Therapeutics
Sollis Therapeutics is a pharmaceutical company developing non-opioid analgesic solutions.
Sequoia Sciences
Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.
Shuttle Pharmaceuticals
Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.
Sinovac Biotech
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization
Dignify Therapeutics
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Dermira
Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
Domain Therapeutics
Domain Therapeutics develops small molecules targeting G-coupled protein receptors.
Immune Pharmaceuticals
Immune Pharmaceuticals applies a personalized approach to treatment and developing novel antibody therapeutics.
Intensity Therapeutics
Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
Invectys Therapeutics
Invectys Therapeutics is a biopharmaceutical company focused on the development of immunotherapy approaches to treat cancer.
Idun Pharmaceuticals
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics
Ocumension Therapeutics
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
Outlook Therapeutics
Outlook Therapeutics is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics.
Ocera Therapeutics
Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
Cirius Therapeutics
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company.
CytomX Therapeutics
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.
Cocrystal Pharma
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.
Compass Therapeutics, Inc.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Cybrexa Therapeutics
Cybrexa Therapeutics is a cancer therapeutics company developing a new class of small molecule DNA repair.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Cellerant Therapeutics
Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Pluri
Pluri is at the forefront of a biotech revolution that promotes global well-being and sustainability.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.
Pear Therapeutics
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Protalix BioTherapeutics
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.
PharmAkea Therapeutics
PharmAkea is a biopharmaceutical company developing small molecule drug candidates targeting proteins in fibroproliferative diseases.
Phanes Therapeutics
Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases
ProTom International
ProTom International is a leading device manufacturer of proton therapy technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-08 | Confluence Life Sciences | Confluence Life Sciences acquired by Aclaris Therapeutics | 100 M USD |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Aclaris Therapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Aclaris Therapeutics
Aisling Capital
Aisling Capital investment in Post-IPO Equity - Aclaris Therapeutics
Mossrock Capital
Mossrock Capital investment in Series C - Aclaris Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Aclaris Therapeutics
Vivo Capital
Vivo Capital investment in Series C - Aclaris Therapeutics
Aperture Venture Partners
Aperture Venture Partners investment in Series C - Aclaris Therapeutics
F-Prime Capital
F-Prime Capital investment in Series C - Aclaris Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Aclaris Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series C - Aclaris Therapeutics
Official Site Inspections
http://www.aclaristx.com Semrush global rank: 3.88 M Semrush visits lastest month: 3.33 K
- Host name: 1086923.cloudwaysapps.com
- IP address: 161.35.96.63
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Aclaris Therapeutics"
Overview | Aclaris Therapeutics Inc.
Aclaris operates Confluence Discovery Technologies, Inc., a full-service drug discovery and early development contract research organization, as an indirect, wholly-owned subsidiary. …See details»
Aclaris Support | Aclaris Therapeutics Inc.
Apply for investigator-initiated study support by sending a message to [email protected]. ... Requests for charitable contributions should be on the requesting organization’s letterhead and include: Name of organization, …See details»
Press Release - investor.aclaristx.com
Nov 18, 2024 For additional information, please visit www.aclaristx.com. Cautionary Note Regarding Forward-Looking Statements. Any statements contained in this press release that …See details»
Aclaris Therapeutics Provides Corporate Update | Aclaris …
Dec 19, 2023 For additional information, please visit www.aclaristx.com. Cautionary Note Regarding Forward-Looking Statements Any statements contained in this press release that …See details»
Aclaris Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number (484) 324-7933 Aclaris Therapeutics started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development …See details»
Aclaris Therapeutics Announces Leadership Changes and Strategic ...
Jan 16, 2024 For additional information, please visit www.aclaristx.com. Cautionary Note Regarding Forward-Looking Statements. Any statements contained in this press release that …See details»
Aclaris Therapeutics, Inc. | LinkedIn
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases …See details»
Aclaris Therapeutics Announces Leadership Changes and Strategic ...
Jan 16, 2024 - Douglas Manion, M.D. to step down as Chief Executive Officer, President and Member of Board of Directors - - Dr. Neal Walker, Current Chairman and Co-founder, …See details»
Aclaris Therapeutics Announces Exclusive, Global License …
Nov 18, 2024 - Enhances Aclaris’ pipeline with complementary biologics portfolio -- Expands leadership team with addition of seasoned biotech executives -- Management to host …See details»
Aclaris Therapeutics Provides Corporate Update - Yahoo Finance
Dec 19, 2023 - ATI-1777 Phase 2a Trial Results Published in JID Innovations -- ATI-1777 Phase 2b Trial Topline Data Anticipated in January 2024 -- Aclaris Announces Reduction in …See details»
Press Releases - Aclaris Therapeutics, Inc.
Jun 6, 2024 [email protected]. Press Releases. Press Releases Year. November 26, 2024 Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare …See details»
Aclaris Therapeutics Announces Exclusive, Global ... - Markets Insider
Nov 18, 2024 To access the live webcast of the call and the accompanying slide presentation, please visit the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com.See details»
Careers | Aclaris Therapeutics Inc.
We are an organization with a commitment to advancing innovation in immuno-inflammatory conditions, a patient-centric sense of purpose, and a high level of professional integrity. …See details»
Aclaris Therapeutics - Overview, News & Similar companies
Aug 11, 2024 Aclaris Therapeutics contact info: Phone number: (484) 324-7933 Website: www.aclaristx.com What does Aclaris Therapeutics do? Aclaris Therapeutics, Inc. is a clinical …See details»
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2022 ...
WAYNE, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug …See details»
Aclaris Therapeutics Reports Third Quarter 2024 Financial Results …
Nov 6, 2024 For additional information, please visit www.aclaristx.com. Cautionary Note Regarding Forward-Looking Statements. Any statements contained in this press release that …See details»
Aclaris Therapeutics Expands Leadership Team - Yahoo Finance
Aug 1, 2022 Appoints Douglas Manion, M.D., FRCP (C), as President and COO WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical …See details»
Aclaris Therapeutics Reports Second Quarter 2024 Financial …
Aug 7, 2024 Aclaris Therapeutics, Inc.-Initiated Phase 2a Study Activities for ATI-2138 in Atopic Dermatitis--Strengthened Balance Sheet Through Sale of Future OLUMIANT ® Royalties for …See details»
Aclaris Therapeutics Announces Top-line Results from 4-Week …
Jan 10, 2024 ATI-1777-AD-202 was a Phase 2b, multicenter, randomized, double-blind, vehicle-controlled, parallel-group clinical trial to evaluate the efficacy, safety, tolerability and …See details»